# Ikove Startup Nursery

Ikove Startup Nursery is a Private Equity based in Columbus, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Columbus, United States
- **Region:** North America
- **Address:** Columbus, OH, United States
- **Founded:** 2014
- **Assets under management:** $250M+
- **Website:** ikovecapital.com
- **LinkedIn:** https://www.linkedin.com/company/ikove-capital-partners

## Regulatory record

- **Reports private funds:** No

## About

Ikove Startup Nursery offers expert support for entrepreneurs looking to launch and grow their startup. Our program provides funding, mentorship, and resources to help your startup succeed. Learn more about our program and apply today.

## Sectors

- Enterprise Software
- AI/ML
- AgriTech & FoodTech
- Digital Health
- FinTech

## Offices

- São Paulo, Brazil

## People

- Flavio Lobato — Managing Partner & Co-Founder
- Johnny Hwin — Managing Partner & Co-Founder
- Marcio R. Campos — Co-Founder

## Questions

### How does Ikove's 'nursery' model differ from a standard startup studio or accelerator?

Ikove operates a 12-month internal R&D phase before company formation — its employed engineers and product managers validate the market, build the MVP, and conduct customer discovery. The firm only hires a founding CEO once product-market fit signals are clear. This moves technical risk inside the firm, whereas most accelerators accept external founding teams at application and compress validation into weeks.

### Who runs investment decisions at Ikove Startup Nursery?

Managing Partners Flavio Lobato and Johnny Hwin make investment committee decisions alongside Co-Founder Marcio R. Campos. Lobato, based in Columbus, leads fund strategy and LP relations, while Hwin and Campos guide the São Paulo R&D operation and deal origination pipeline. All three were previously affiliated with CESAR, the Brazilian innovation institute where the nursery methodology was piloted.

### What is Ikove's connection to the Brazilian innovation ecosystem?

Ikove maintains a major R&D studio in São Paulo with roots at CESAR, the Recife-based innovation lab where the founders previously worked. The Brazilian operation provides subsidized engineering talent, customer discovery infrastructure, and a beachhead for deep-tech ideas that require cost-efficient technical validation before transferring to the U.S. market. This cross-border pipeline is Ikove's primary talent moat.

### Which sectors does Ikove explicitly avoid?

The firm stays away from consumer social media, pure-play e-commerce, and hardware with long prototyping cycles outside its AgriTech focus. Ikove's public portfolio broadly excludes biotech therapeutics requiring FDA approval, crypto tokens, and enterprise businesses that depend on government procurement as the primary revenue source. Investment scope is explicitly limited to deep-tech verticals where the internal R&D bench can add value.

### Who backs Ikove itself — who are its limited partners?

Ikove's disclosed LP relationships include the Ohio Innovation Fund, Rev1 Ventures, and Ohio Third Frontier — state-backed economic-development vehicles that align with the firm's mission to build technology companies in the Midwest. The firm has not disclosed a total AUM number, but public records of these commitments, combined with the self-described ~5-company annual output at $400,000–$1.5 million initial check size, point to a sub-$100 million fund base.

## Related profiles

- [IKJ Capital](https://altss.com/profile/ikj-capital)
- [IK Partners](https://altss.com/profile/ik-partners)

---

Last updated: 2026-07-08T23:22:46.846Z

Canonical page: https://altss.com/profile/ikove-startup-nursery

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology
